(Q36421977)

14 August 2017

Evidence for divergence of DNA copy number changes in serous, mucinous and endometrioid ovarian carcinomas (English)

1 reference

14 August 2017

Tapper J

1

1 reference

14 August 2017

Bützow R

2

1 reference

14 August 2017

Wahlström T

3

1 reference

14 August 2017

Seppälä M

4

1 reference

14 August 2017

Knuutila S

5

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

75

1 reference

14 August 2017

1782-1787

1 reference

14 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1997.304

14 August 2017

0 references

cites work

Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

A cell cycle regulator potentially involved in genesis of many tumor types

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Localization of the human gene for Src-related protein tyrosine kinase LYN to chromosome 8q11-12: a lymphoid signaling cluster?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Genetic analysis of benign, low-grade, and high-grade ovarian tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Mutation analysis of the BRCA1 gene in ovarian cancers.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

K-ras activation in neoplasms of the human female reproductive tract

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

p53 protein detected by immunohistochemistry as a prognostic factor in patients with epithelial ovarian carcinoma

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Human epithelial ovarian cancer allelotype.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2223609

Cytogenetic studies in ovarian cancer

21 September 2018

1 reference

12 December 2020

Overrepresentation of 3q and 8q material and loss of 18q material are recurrent findings in advanced human ovarian cancer

1 reference

12 December 2020

Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1

1 reference

12 December 2020

Protooncogene amplification and tumor ploidy in human ovarian neoplasms

1 reference

12 December 2020

Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer

1 reference

12 December 2020

Overexpression and mutation of p53 in epithelial ovarian cancer

1 reference

12 December 2020

Chromosome aberrations in 35 primary ovarian carcinomas

1 reference

12 December 2020

Fine-scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers

1 reference

12 December 2020

Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy

1 reference

12 December 2020

Mutation and overexpression of p53 in early-stage epithelial ovarian cancer

1 reference

12 December 2020

HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples

1 reference

12 December 2020

p53 accumulation in ovarian carcinomas and its prognostic implications

1 reference

12 December 2020

Mutation of K-ras protooncogene is associated with histological subtypes in human mucinous ovarian tumors

1 reference

12 December 2020

Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus

1 reference

12 December 2020

The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer

1 reference

12 December 2020

DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.304

1 reference

14 August 2017

1 reference

14 August 2017

1 reference